Expand bio therapeutics access by developing faster, alternative testing methods: Dr Harish Chander
Dr Chander interacted with ETPharma and discussed what NIB is doing currently and how they intend to scale advanced and alternate methods of testing bio therapeutics.
Advertisement
More

- Exclusive
Focusing on Volume and Revenue Growth with Expanding Margins Amid Lab Expansion: Ameera Shah
- Exclusive

- Exclusive
BioE3 will lead the way in sustainable biotechnology, precision medicine: Dr Rajesh Gokhale
- Exclusive
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions